Visceral Leishmaniasis: Advancements in vaccine development via classical and molecular approaches

Visceral Leishmaniasis: Advancements in vaccine development via classical and molecular approaches

Visceral Leishmaniasis (VL) or kala-azar, a vector-borne protozoan disease, shows endemicity in larger areas of the tropical, subtropical and the Mediterranean countries. WHO report suggested that nearly 500,000 new cases of VL occur annually, including 100,000 cases from India itself. Treatment wit...

Full description

Bibliographic Details
Main Authors: Sumit eJoshi, Keerti eRawat, Narendra Kumar Yadav, Vikash eKumar, Mohammed Imran Siddiqi, Anuradha eDube
Format: Article
Language:English
Published: Frontiers Media S.A. 2014-08-01
Series:Frontiers in Immunology
Subjects:
Visceral leishmaniasis
DNA Vaccines
mutant vaccines
recombinant vaccines
synthetic peptide vaccines
Online Access:http://journal.frontiersin.org/Journal/10.3389/fimmu.2014.00380/full

Internet

http://journal.frontiersin.org/Journal/10.3389/fimmu.2014.00380/full

Similar Items